Can a common drug stop infections before they start?
NCT ID NCT07054320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether the drug rapamycin (sirolimus) can help prevent infections or make them less severe. Fifteen adults will take the drug for 6 months while researchers monitor their health through blood tests, heart checks, and surveys. The goal is to see if rapamycin is safe and effective for reducing infection-related illness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Male and female adults, 18 years and older
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or Female Adults, 18 years and older * Females of child-bearing age taking birth control medication * Received a Hoskinson Health and Wellness Clinic physician prescription for Rapamune (Sirolimus) Exclusion Criteria: * Adults requiring monoclonal antibody or biological treatment * Adults diagnosed with an acute lower respiratory or GI infection within 2 weeks * Adults females who are not taking birth control medication, are pregnant or nursing mothers * Adults reporting severe mental or physical disability * Adults reporting unwillingness to travel to onsite clinical facilities * Adults with any change in chronic disease symptoms or medication within 3 months * Any contraindications to medical treatment with Rapamune (Sirolimus), as outlined in the FDA-approved medication guide
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infectious diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hoskinson Health and Wellness Clinic
Gillette, Wyoming, 82718, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do childhood infections shape a lifetime of immunity?
- DNA test for infections: can it guide antibiotic decisions?
- Can a common steroid tame severe flu in the ICU?
- Putting dietitians in charge of hospital nutrition: a recipe for shorter stays?
- 23,000 seniors join study to unlock secrets of aging and infection
- Cash for breastfeeding: a new way to boost baby health?